1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RNA sequencing analysis of non-uterine leiomyosarcomas for outcome risk prediction
    Meeting Abstract

    Ogawa, M.; Tanaka, A.; Namba, K.; Agaram, N.; Roehrl, M.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • Copy number alterations outside 12q13-15 in well-differentiated/ dedifferentiated liposarcomas
    Meeting Abstract

    Castillo, N. G.; Vanderbilt, C.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling of EWSR1/FUS-CREB family of translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates
    Meeting Abstract

    Dermawan, J.; Vanoli, F.; Zhang, L.; Center, M.; Bale, T.; Dickson, B.; Antonescu, C.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • Low grade adenosquamous carcinoma of the breast: A clinicopathologic review of 34 cases
    Meeting Abstract

    Cartagena, L. C.; Brogi, E.; Reis-Filho, J.; Wen, H.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • The spectrum of breast cancer with TERT genetic alterations
    Meeting Abstract

    Cartagena, L. C.; Gazzo, A.; da Silva, E. M.; Derakhshan, F.; Marra, A.; Ross, D.; D'Alfonso, T.; Zhang, H.; Wen, H.; Weigelt, B.; more...
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • Breast nonmass enhancement and histologic findings at needle core biopsy: A single institution experience
    Meeting Abstract

    Cagaanan, A.; Hanna, M.; Brennan, S.; Brogi, E.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization
    Meeting Abstract

    Yip, W.; Kim, K.; Kuo, F.; Lenis, A. T.; Chen, J. F.; Hu, W.; Clinton, T. N.; Chu, C. E.; Almassi, N.; Tracey, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Yip, W.; Coleman, J.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management
    Meeting Abstract

    Truong, H.; Sheikh, R.; Kemel, Y.; De Jesus Escano, M.; Khurram, A.; Reisz, P.; Lenis, A. T.; Goh, A. C.; Cha, E. K.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma
    Meeting Abstract

    Chu, C. E.; De Jesus Escano, M.; Yip, W.; Jiang, S.; Iyer, G.; Al-Ahmadie, H. A.; Goh, A. C.; Dalbagni, G.; Bochner, B. H.; Solit, D. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save